NOSSAMAN LLP for AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP")
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
H.R.1392 and S.1221, legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. America's Healthy Future Act of 2009, health reform legislation in the Senate Finance Committee. H.R.3200, America's Affordable Health Choices Act of 2009.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY W JENKINS | — |
| SHERRY HARPER WIDICUS | Legislative Director, Congressman Ron Kind |
Pharmacy PHA
H.R.1392 and S.1221, legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. America's Healthy Future Act of 2009, health reform legislation in the Senate Finance Committee. H.R.3200, America's Affordable Health Choices Act of 2009.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY W JENKINS | — |
| SHERRY HARPER WIDICUS | Legislative Director, Congressman Ron Kind |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.